Revised FDA Form 2830 Blood Establishment Registration and Product Listing (8/95); Availability

Samenvatting

The Food and Drug Administration (FDA) is announcing the availability of the revised FDA Form 2830 Blood Establishment Registration and Product Listing (8/95). This form replaces the previous edition of FDA Form 2830 (7/93). FDA Form 2830 is used for blood establishment registration and product listing, in accordance with the agency's regulations. FDA has made minor changes to the blood establishment registration and product listing which are intended to update the form, simplify processing, provide for efficient and effective use of the data base, and decrease expenditure of resources for both FDA and industry.